The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Next Generation Sequencers-Global Market Insights and Sales Trends 2025
Synopsis
Next generatio sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.
Knowledge of DNA sequences has become indispensable for basic biological research, and in numerous applied fields such as medical diagnosis, biotechnology, forensic biology, virology and biological systematics. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of complete DNA sequences, or genomes of numerous types and species of life, including the human genome and other complete DNA sequences of many animal, plant, and microbial species.
The global Next Generation Sequencers market size is expected to reach US$ 4346.4 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Next Generation Sequencers in various end use industries. The expanding demands from the Diagnostics, Drug Discovery, Biomarker Discovery and Others, are propelling Next Generation Sequencers market. Sequencing by Synthesis (SBS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ion Semiconductor Sequencing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Next Generation Sequencers market, driven by demand from China, the second largest economy with some signs of stabilising, the Next Generation Sequencers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Next Generation Sequencers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Next Generation Sequencers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Next Generation Sequencers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Next Generation Sequencers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Next Generation Sequencers covered in this report include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg) and Oxford Nanopore Technologies, Ltd. (UK), etc.
The global Next Generation Sequencers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
Global Next Generation Sequencers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Next Generation Sequencers market, Segment by Type:
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Global Next Generation Sequencers market, by Application
Diagnostics
Drug Discovery
Biomarker Discovery
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Next Generation Sequencers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Next generatio sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.
Knowledge of DNA sequences has become indispensable for basic biological research, and in numerous applied fields such as medical diagnosis, biotechnology, forensic biology, virology and biological systematics. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of complete DNA sequences, or genomes of numerous types and species of life, including the human genome and other complete DNA sequences of many animal, plant, and microbial species.
The global Next Generation Sequencers market size is expected to reach US$ 4346.4 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Next Generation Sequencers in various end use industries. The expanding demands from the Diagnostics, Drug Discovery, Biomarker Discovery and Others, are propelling Next Generation Sequencers market. Sequencing by Synthesis (SBS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ion Semiconductor Sequencing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Next Generation Sequencers market, driven by demand from China, the second largest economy with some signs of stabilising, the Next Generation Sequencers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Next Generation Sequencers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Next Generation Sequencers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Next Generation Sequencers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Next Generation Sequencers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Next Generation Sequencers covered in this report include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg) and Oxford Nanopore Technologies, Ltd. (UK), etc.
The global Next Generation Sequencers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
Global Next Generation Sequencers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Next Generation Sequencers market, Segment by Type:
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Global Next Generation Sequencers market, by Application
Diagnostics
Drug Discovery
Biomarker Discovery
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Next Generation Sequencers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Next Generation Sequencers
1.1 Next Generation Sequencers Market Overview
1.1.1 Next Generation Sequencers Product Scope
1.1.2 Next Generation Sequencers Market Status and Outlook
1.2 Global Next Generation Sequencers Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Next Generation Sequencers Market Size by Region (2018-2029)
1.4 Global Next Generation Sequencers Historic Market Size by Region (2018-2023)
1.5 Global Next Generation Sequencers Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Next Generation Sequencers Market Size (2018-2029)
1.6.1 North America Next Generation Sequencers Market Size (2018-2029)
1.6.2 Europe Next Generation Sequencers Market Size (2018-2029)
1.6.3 Asia-Pacific Next Generation Sequencers Market Size (2018-2029)
1.6.4 Latin America Next Generation Sequencers Market Size (2018-2029)
1.6.5 Middle East & Africa Next Generation Sequencers Market Size (2018-2029)
2 Next Generation Sequencers Market by Type
2.1 Introduction
2.1.1 Sequencing by Synthesis (SBS)
2.1.2 Ion Semiconductor Sequencing
2.1.3 Single-Molecule Real-time (SMRT) Sequencing
2.1.4 Other
2.2 Global Next Generation Sequencers Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Next Generation Sequencers Historic Market Size by Type (2018-2023)
2.2.2 Global Next Generation Sequencers Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Next Generation Sequencers Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Next Generation Sequencers Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Next Generation Sequencers Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Next Generation Sequencers Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Next Generation Sequencers Revenue Breakdown by Type (2018-2029)
3 Next Generation Sequencers Market Overview by Application
3.1 Introduction
3.1.1 Diagnostics
3.1.2 Drug Discovery
3.1.3 Biomarker Discovery
3.1.4 Others
3.2 Global Next Generation Sequencers Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Next Generation Sequencers Historic Market Size by Application (2018-2023)
3.2.2 Global Next Generation Sequencers Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Next Generation Sequencers Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Next Generation Sequencers Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Next Generation Sequencers Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Next Generation Sequencers Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Next Generation Sequencers Revenue Breakdown by Application (2018-2029)
4 Next Generation Sequencers Competition Analysis by Players
4.1 Global Next Generation Sequencers Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next Generation Sequencers as of 2022)
4.3 Date of Key Players Enter into Next Generation Sequencers Market
4.4 Global Top Players Next Generation Sequencers Headquarters and Area Served
4.5 Key Players Next Generation Sequencers Product Solution and Service
4.6 Competitive Status
4.6.1 Next Generation Sequencers Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina, Inc. (US)
5.1.1 Illumina, Inc. (US) Profile
5.1.2 Illumina, Inc. (US) Main Business
5.1.3 Illumina, Inc. (US) Next Generation Sequencers Products, Services and Solutions
5.1.4 Illumina, Inc. (US) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina, Inc. (US) Recent Developments
5.2 Thermo Fisher Scientific, Inc. (US)
5.2.1 Thermo Fisher Scientific, Inc. (US) Profile
5.2.2 Thermo Fisher Scientific, Inc. (US) Main Business
5.2.3 Thermo Fisher Scientific, Inc. (US) Next Generation Sequencers Products, Services and Solutions
5.2.4 Thermo Fisher Scientific, Inc. (US) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific, Inc. (US) Recent Developments
5.3 Pacific Biosciences of California, Inc. (US)
5.3.1 Pacific Biosciences of California, Inc. (US) Profile
5.3.2 Pacific Biosciences of California, Inc. (US) Main Business
5.3.3 Pacific Biosciences of California, Inc. (US) Next Generation Sequencers Products, Services and Solutions
5.3.4 Pacific Biosciences of California, Inc. (US) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Holding AG (Switzerland) Recent Developments
5.4 Roche Holding AG (Switzerland)
5.4.1 Roche Holding AG (Switzerland) Profile
5.4.2 Roche Holding AG (Switzerland) Main Business
5.4.3 Roche Holding AG (Switzerland) Next Generation Sequencers Products, Services and Solutions
5.4.4 Roche Holding AG (Switzerland) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Holding AG (Switzerland) Recent Developments
5.5 QIAGEN N. V. (Germany)
5.5.1 QIAGEN N. V. (Germany) Profile
5.5.2 QIAGEN N. V. (Germany) Main Business
5.5.3 QIAGEN N. V. (Germany) Next Generation Sequencers Products, Services and Solutions
5.5.4 QIAGEN N. V. (Germany) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.5.5 QIAGEN N. V. (Germany) Recent Developments
5.6 BGI (China)
5.6.1 BGI (China) Profile
5.6.2 BGI (China) Main Business
5.6.3 BGI (China) Next Generation Sequencers Products, Services and Solutions
5.6.4 BGI (China) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.6.5 BGI (China) Recent Developments
5.7 Macrogen Inc. (South Korea)
5.7.1 Macrogen Inc. (South Korea) Profile
5.7.2 Macrogen Inc. (South Korea) Main Business
5.7.3 Macrogen Inc. (South Korea) Next Generation Sequencers Products, Services and Solutions
5.7.4 Macrogen Inc. (South Korea) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.7.5 Macrogen Inc. (South Korea) Recent Developments
5.8 Eurofins Scientific (Luxembourg)
5.8.1 Eurofins Scientific (Luxembourg) Profile
5.8.2 Eurofins Scientific (Luxembourg) Main Business
5.8.3 Eurofins Scientific (Luxembourg) Next Generation Sequencers Products, Services and Solutions
5.8.4 Eurofins Scientific (Luxembourg) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.8.5 Eurofins Scientific (Luxembourg) Recent Developments
5.9 Oxford Nanopore Technologies, Ltd. (UK)
5.9.1 Oxford Nanopore Technologies, Ltd. (UK) Profile
5.9.2 Oxford Nanopore Technologies, Ltd. (UK) Main Business
5.9.3 Oxford Nanopore Technologies, Ltd. (UK) Next Generation Sequencers Products, Services and Solutions
5.9.4 Oxford Nanopore Technologies, Ltd. (UK) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.9.5 Oxford Nanopore Technologies, Ltd. (UK) Recent Developments
5.10 Otogenetics Corporation (US)
5.10.1 Otogenetics Corporation (US) Profile
5.10.2 Otogenetics Corporation (US) Main Business
5.10.3 Otogenetics Corporation (US) Next Generation Sequencers Products, Services and Solutions
5.10.4 Otogenetics Corporation (US) Next Generation Sequencers Revenue (US$ Million) & (2018-2023)
5.10.5 Otogenetics Corporation (US) Recent Developments
6 North America
6.1 North America Next Generation Sequencers Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Next Generation Sequencers Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencers Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Next Generation Sequencers Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencers Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Next Generation Sequencers Market Dynamics
11.1 Next Generation Sequencers Industry Trends
11.2 Next Generation Sequencers Market Drivers
11.3 Next Generation Sequencers Market Challenges
11.4 Next Generation Sequencers Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
